Literature DB >> 30661180

HIV, Depression, and Cognitive Impairment in the Era of Effective Antiretroviral Therapy.

Leah H Rubin1,2, Pauline M Maki3,4.   

Abstract

PURPOSE OF REVIEW: Mental health disorders, especially depression, are prevalent among people living with HIV (PLWH) and are associated with cognitive impairment (CI) among HIV-uninfected (HIV-) individuals. We conducted a comprehensive review of the link between depression and cognition among PLWH. RECENT
FINDINGS: Studies examining depression and cognition in PLWH report high rates of current (median = 24%) and lifetime depression (42%). There is reliable evidence that depression is associated with overall CI among PLWH, and in the cognitive domains of processing speed, executive function, learning and memory, and motor function. Although few studies have examined the interaction between HIV serostatus and depression on CI, there is no evidence of a stronger association between CI and depression in PLWH compared with HIV- controls. Depression is prevalent and reliably associated with CI in PLWH, with an overall pattern of domain-specific associations similar to that of HIV- individuals.

Entities:  

Keywords:  Cognitive impairment; Depression; Depressive symptoms; HAND; HIV

Mesh:

Substances:

Year:  2019        PMID: 30661180      PMCID: PMC6420829          DOI: 10.1007/s11904-019-00421-0

Source DB:  PubMed          Journal:  Curr HIV/AIDS Rep        ISSN: 1548-3568            Impact factor:   5.071


  49 in total

Review 1.  Comorbid HIV infection and alcohol use disorders: Converging glutamatergic and dopaminergic mechanisms underlying neurocognitive dysfunction.

Authors:  Laura L Giacometti; Jacqueline M Barker
Journal:  Brain Res       Date:  2019-08-14       Impact factor: 3.252

2.  Elevated Depressive Symptoms Are a Stronger Predictor of Executive Dysfunction in HIV-Infected Women Than in Men.

Authors:  Leah H Rubin; Gayle Springer; Eileen M Martin; Eric C Seaberg; Ned C Sacktor; Andrew Levine; Victor G Valcour; Mary A Young; James T Becker; Pauline M Maki
Journal:  J Acquir Immune Defic Syndr       Date:  2019-07-01       Impact factor: 3.731

Review 3.  A Review of Interventions to Enhance HIV Medication Adherence.

Authors:  Laura B Whiteley; Elizabeth M Olsen; Kayla K Haubrick; Enyonam Odoom; Nicholas Tarantino; Larry K Brown
Journal:  Curr HIV/AIDS Rep       Date:  2021-06-21       Impact factor: 5.071

Review 4.  An Empirical Mediation Analysis of Mechanisms Underlying HIV-1-Associated Neurocognitive Disorders.

Authors:  Kristen A McLaurin; Charles F Mactutus; Rosemarie M Booze; Amanda J Fairchild
Journal:  Brain Res       Date:  2019-09-09       Impact factor: 3.252

5.  Heterogeneity in neurocognitive change trajectories among people with HIV starting antiretroviral therapy in Rakai, Uganda.

Authors:  Leah H Rubin; Deanna Saylor; Gertrude Nakigozi; Noeline Nakasujja; Kevin Robertson; Alice Kisakye; James Batte; Richard Mayanja; Aggrey Anok; Sarah M Lofgren; David R Boulware; Raha Dastgheyb; Steven J Reynolds; Thomas C Quinn; Ronald H Gray; Maria J Wawer; Ned Sacktor
Journal:  J Neurovirol       Date:  2019-06-19       Impact factor: 2.643

6.  Female sex is strongly associated with cognitive impairment in HIV infection.

Authors:  Eric Andrius Coelho Duarte; Maria Luiza Benevides; André Luiz Pereira Martins; Edson Pillotto Duarte; Ana Beatriz Santandrea Weller; Laura Oliveira Coutinho de Azevedo; Maria Emília Rodrigues de Oliveira Thaís; Jean Costa Nunes
Journal:  Neurol Sci       Date:  2020-09-14       Impact factor: 3.307

7.  Depressive Symptoms Differentially Predict Neurocognition in Latinx and Non-Hispanic White People Living with HIV.

Authors:  Emily P Morris; Desiree Byrd; Angela C Summers; Kayla Tureson; Vanessa Guzman; Cara L Crook; Monica Rivera Mindt
Journal:  J Int Neuropsychol Soc       Date:  2020-09-24       Impact factor: 2.892

8.  Lower CSF homovanillic acid relates to higher burden of neuroinflammation and depression in people with HIV disease.

Authors:  Rowan Saloner; Mariana Cherner; David J Grelotti; Emily W Paolillo; David J Moore; Robert K Heaton; Scott L Letendre; Adarsh Kumar; Igor Grant; Ronald J Ellis
Journal:  Brain Behav Immun       Date:  2020-09-20       Impact factor: 7.217

Review 9.  Bidirectional Associations among Nicotine and Tobacco Smoke, NeuroHIV, and Antiretroviral Therapy.

Authors:  Shivesh Ghura; Robert Gross; Kelly Jordan-Sciutto; Jacob Dubroff; Robert Schnoll; Ronald G Collman; Rebecca L Ashare
Journal:  J Neuroimmune Pharmacol       Date:  2019-12-13       Impact factor: 4.147

10.  Cumulative Burden of Depression and Neurocognitive Decline Among Persons With HIV: A Longitudinal Study.

Authors:  Emily W Paolillo; Elizabeth C Pasipanodya; Raeanne C Moore; Brian W Pence; Joseph Hampton Atkinson; David J Grelotti; Igor Grant; Robert K Heaton; David J Moore
Journal:  J Acquir Immune Defic Syndr       Date:  2020-07-01       Impact factor: 3.731

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.